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ABSTRACT
Howalternative splicing (AS) is regulated in plants has
not yet been elucidated. Previously, we have shown
that the nuclear cap-binding protein complex (AtCBC)
is involved in AS in Arabidopsis thaliana. Here we
show that both subunits of AtCBC (AtCBP20 and
AtCBP80) interact with SERRATE (AtSE), a protein
involved in the microRNA biogenesis pathway.
Moreover, using a high-resolution reverse transcript-
ase-polymerase chain reaction AS system we have
found that AtSE influences AS in a similar way to the
cap-binding complex (CBC), preferentially affecting
selection of 50 splice site of first introns. The AtSE
protein acts in cooperation with AtCBC: many
changes observed in the mutant lacking the correct
SERRATE activity were common to those observed in
the cbp mutants. Interestingly, significant changes in
AS of some genes were also observed in other
mutants of plant microRNA biogenesis pathway,
hyl1-2 and dcl1-7, but a majority of them did not cor-
respond to the changes observed in the se-1mutant.
Thus, the role of SERRATE in AS regulation is distinct
from that of HYL1 andDCL1, and is similar to the regu-
lation of AS in which CBC is involved.
INTRODUCTION
Alternative splicing (AS) is a widespread process that gen-
erates more than one spliced mRNA isoform from the
same gene. One of the major consequences of AS is to
increase protein diversity by the inclusion or exclusion of
peptide sequences or protein domains. The number of
genes that undergo AS is 95% in human (1,2), and has
recently increased to >60% of intron-containing genes in
Arabidopsis thaliana (3,4). More than 75% of AS events
occur within the coding sequence of the genes, and can
generate proteins with new structures and biological func-
tions (5–8). However, a signiﬁcant number of AS events in
coding regions generates premature termination codons,
which potentially target transcripts for degradation by the
nonsense-mediated decay (NMD) pathway. Thus, AS can
also modulate gene expression through the production of
mRNA isoforms, which are degraded by NMD (3,6,9–13).
In both plants and animals, 20% of all AS events take
place within untranslated regions: 50 UTR (12–15%) or 30
UTR (3–6%), which can affect transport and stability of
mRNAs, create new initiation codons or polyadenylation
sites, generate upstream open reading frames, trigger
NMD or shift the reading frame (13–15).
AS events include alternative 50 and 30 splice site
selection, intron retention, exon skipping and mutually
exclusive exon splicing (5,16,17). In plants, intron reten-
tion is the most frequent alternative event (45–56%)
(6,11,14,18,19) but appears to have much less impact at
the transcript level (4). Alternative 30 and 50 splice sites
account for 22 and 10% of events, respectively, and
4% have both 50 and 30 alternatively spliced sites. Only
8% of alternative events in plants involve exon skipping,
in contrast to animals where exon skipping is the most
common form of AS (58% of events) (6,15,19,20). AS of
some genes in plants is evolutionarily conserved, suggest-
ing its important role in plant development (21). The best-
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characterized example is that of serine/arginine (SR)
protein splicing factor genes that undergo frequent AS.
Moreover, SR proteins can regulate the AS of their own
pre-mRNA, pre-mRNAs of other SR proteins and of
target genes (22–28). With the exception of SR proteins,
PTB and GRP7, little is known about proteins that
regulate AS in plants (22–34). Previously we have shown
that the plant nuclear cap-binding complex (CBC), con-
sisting of two subunits (CBP20 and CBP80), can inﬂuence
AS preferentially affecting AS of the ﬁrst intron, and par-
ticularly at the 50 splice site (35).
It has been shown that inactivation of either the
AtCBP80 or AtCBP20 genes leads to pleiotropic develop-
mental defects similar to the phenotype observed in
Arabidopsis mutants of SERRATE (AtSE) (36–39).
SERRATE is a zinc ﬁnger protein that is mostly localized
in nuclear Dicing-bodies (D-bodies), and plays a crucial
role in microRNA (miRNA) biogenesis in plants. AtSE
acts together with the endonuclease DICER-LIKE 1
(DCL1) and the double-stranded RNA-binding protein
HYL1, in efﬁcient and accurate processing of primary
miRNAs (pri-miRNAs) to mature miRNAs (36,40–42).
However, in cbc mutants, reduced miRNA levels and
increased pri-miRNA levels were also observed (43–45),
suggesting that both, AtSE and the CBC complex, have
a role in miRNA biogenesis. Similarly, in the se-1 mutant,
accumulation of some partially spliced pre-mRNAs was
also described, suggesting a role for AtSE in splicing of
mRNAs (43). Interestingly, the loss of either AtCBC or
AtSE activity often affected splicing of the ﬁrst intron in a
transcript (35,43).
In this article, using Bimolecular Fluorescence
Complementation (BiFC), pull-down and co-immunopre-
cipitation experiments, we show that both subunits of
AtCBC, AtCBP20 and AtCBP80 interact with AtSE.
Moreover, we used the sensitive high-resolution reverse
transcriptase-polymerase chain reaction (RT-PCR) AS
panel (13,31,35,46) to analyze the effect of the se-1
mutation on the AS proﬁles of 285 Arabidopsis genes.
We have found that AtSE inﬂuences AS of a number of
genes often affecting selection of 50 splice site of ﬁrst
introns, similar to AtCBC, suggesting that the CBC and
SERRATE cooperate in selection of alternative splice
sites. Additionally, using RNA immunoprecipitation
(RIP) we show that AtSE can directly bind selected
target RNAs, conﬁrming its role as a splicing regulator.
We also found that changes observed in the se-1 mutant
did not correspond with the changes observed in
Arabidopsis mutants of other key proteins that interact
with AtSE, and are involved in plant miRNA biogenesis,
hyl1-2 and dcl1-7, suggesting that SERRATE has a
function in regulation of AS in plants, which is distinct
from its role in miRNA biogenesis.
MATERIALS AND METHODS
Plant material and growth conditions
Arabidopsis thaliana wild type and mutant lines in the
Columbia (Col-0) ecotype were used for all analyses: the
homozygous T-DNA insertion lines hyl1-2
(SALK_064863) (47) and the point mutants se-1 (48)
and dcl1-7 (49). Plants were grown in a growth chamber
(SANYO MLR-350H) under controlled environmental
parameters: humidity of 70%, temperature 22C, 16 h
light/8 h dark photoperiod regime at 150–
200 mmolm2s1. Rosette leaves were harvested 35 days
after sowing seeds, and frozen in liquid nitrogen. For
each experiment, at least three biological replicates were
harvested. Homozygous dcl1-7 plants were identiﬁed using
PCR. Arabidopsis thaliana (L.) Heynh. ecotype Columbia
suspension-cultured T87 cells were grown in a growth
chamber (Gallenkamp) with continuous illumination
(100mmolm2s1) at 22C, with rotary shaking at
120 rpm in mJPL3 medium (50). The cultures were
renewed weekly; 5 days after passaging T87 cells were
used for protoplast preparation.
Preparation of constructs for protein–protein interaction
and subcellular localization studies
For co-localization, full-length (FL) AtCBP80, AtCBP20
and AtSE were ampliﬁed with gene-speciﬁc primers con-
taining SalI and BamHI, or SalI and EcoRI restriction
sites, and were then cloned into pSAT6-ECFP-C1 or
pSAT4-EYFP-C1 (51), resulting in pSAT6-ECFP:AtSE,
pSAT4-EYFP:AtCBP20 and pSAT4-EYFP:AtCBP80.
For the BiFC analysis, PCR products were cloned into
pSAT4-cEYFP-C1-B, pSAT4A-cEYFP-N1, pSAT1-
nEYFP-C1 or pSAT1A-nEYFP-N1 (52), resulting in
pSAT1-nEYFP-AtCBP20, pSAT1A-CBP20-nEYFP,
pSAT4-cEYFP:AtCBP20, pSAT4A-AtCBP20:cEYFP,
pSAT1-nEYFP:AtCBP80, pSAT1A-AtCBP80:nEYFP,
pSAT1-nEYFP:AtSE, pSAT1A-AtSE:nEYFP, pSAT4-
cEYFP:AtSE and pSAT4A-AtSE:cEYFP. For negative
control experiments, free N-terminus of Enhanced Yellow
Fluorescent Protein (nEYFP) and C-terminus of Enhanced
Yellow Fluorescent Protein (cEYFP) fragments (from
pSAT1-nEYFP-C1 and pSAT4-cEYFP-N1, respectively)
in combination with complementary plasmids containing
the protein sequences under study were used. To construct
multicassette BiFC vectors, the expression cassette from
pSAT6A-mRFP-N1 (52) was ﬁrst cloned into the PI-PspI
site of pPZP-RCS2 (53) to produce the pPZP-RCS2-mRFP
vector. Afterward, expression cassettes from previously
prepared pSAT vectors were transferred into the I-SceI
and AscI sites of the pPZP-RCS2-mRFP vector to create
pPZP-RCS2-nEYFP-cYFP:AtCBP20-mRFP and pPZP-
RCS2-nEYFP:AtCBP80-cEYFP-mRFP. Sequences of
inserts were conﬁrmed for each construct. Sequences of
primers used for construct preparation are listed in
Supplementary Table S1.
Protoplast transfection
The fusion constructs used for protein visualization and
BiFC analyses were introduced into A. thaliana proto-
plasts prepared from suspension-cultured T87 cells or
rosette leaves, as described previously (54–56).
Protoplasts were analyzed for ﬂuorescence 20–35 h after
transfection using an epiﬂuorescence microscope
AxioObserver Z1 (Zeiss).
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Microscopy
Subcellular localization of fusion proteins was examined
with a ﬂuorescence microscope AxioObserver Z1 (Zeiss)
equipped with a CCD camera AxioCam MRm (Zeiss)
using a 63 air objective lens, or a confocal laser
scanning microscope SP5 (Leica) using a 63 water ob-
jective lens. For the ﬂuorescence microscope, speciﬁc
ﬁlters for ECFP (excitation 436/20 nm, emission 480/
40 nm) and Enhanced Cyan Fluorescent Protein (EYFP)
(excitation 500/20 nm, emission 535/30 nm) were used.
Excitation in the confocal was achieved with an Argon
laser at 514 nm (EYFP), and with Helium-Neonium
laser at 543 nm monomeric Red Fluorescent Protein
(mRFP). Fluorescence was observed using the emission
spectrum range of 523–560 nm (EYFP) and 571–635 nm
(mRFP). Images were arranged using ADOBE
PHOTOSHOP (Adobe Systems).
Immunoprecipitation
Arabidopsis plants overexpressing AtSE:FLAG and
AtHYL1:FLAG proteins were prepared in the se-1
and hyl1-2 mutant background, respectively. AtSE and
AtHYL1 protein-coding sequence was ampliﬁed using
AtSEfor, AtSErev, AtHYLfor and AtHYLrev primers
(Supplementary Table S1). The products were cloned
into the pEarlyGate202 plasmid, and transformed into
Agrobacterium tumefaciens AGL1. Agrobacterium-
mediated ﬂoral dip transformation was used to introduce
the FLAG-SERRATE transgene into the se-1 mutant
genome, and the FLAG-HYL1 transgene into the hyl1-2
mutant genome. Homozygous transgenic plants had a
restored wild-type phenotype and produced AtSE:FLAG
or AtHYL1:FLAG proteins as conﬁrmed by western blot
(Figure 3A). After 35 days, leaves from control and trans-
genic plants were vacuum-inﬁltrated with 1% formalde-
hyde for 10min, quenched with 125mM glycine and
frozen in liquid nitrogen. The nuclear proteins were ex-
tracted as follows: the frozen material was resuspended in
Buffer I [0.4M sucrose, 10mM Tris–HCl, pH 8.0, 10mM
MgCl2, 0.035% b-mercaptoethanol (b-ME), one protease
inhibitor tablet (Roche) per 50ml of buffer], vortexed vig-
orously, ﬁltered through Miracloth and centrifuged for
30min at 3000g at 4C. The pellet was resuspended in
1ml of Buffer II [0.4M sucrose, 10mM Tris–HCl, pH
8.0, 10mM MgCl2, 0.035% b-ME, 1% Triton X-100,
protease inhibitor tablets (Roche)] and centrifuged for
10min at 12 000g at 4C; this step was repeated two to
three times until a white pellet was visible. After the last
centrifugation, the pellet was resuspended in 300ml of
Buffer II and loaded onto 900 ml of Buffer III [1.7M
sucrose, 10mM Tris–HCl, pH 8.0, 2mM MgCl2,
0.035% b-ME, 0.15% Triton X-100, protease inhibitor
tablets (Roche)]. After 1 h of centrifugation at 16 000g at
4C the pellet containing nuclei was collected and resus-
pended in lysis buffer [10% sucrose, 100mM Tris–HCl,
pH 7.5, 5mM EDTA, 5mM EGTA, 300mM NaCl,
0.75% Triton X-100, 0.15% sodium dodecyl sulphate
(SDS), 1mM dithiothreitol (DTT), protease inhibitor
tablets (Roche)]. After 1 h of shaking at 1000g at 4C,
the sample was centrifuged for 15min at 14 000g at 4C,
and the supernatant containing nuclear protein lysate was
collected. For co-immunoprecipitation experiments, anti-
FLAG antibody-coupled magnetic beads (Sigma) were
gently rotated overnight at 4 with the nuclear protein
lysate, then washed four times with lysis buffer and
eluted by boiling in sample buffer (50mM Tris–HCl, pH
6.8, 10% glycerol, 2% SDS, 10mM DTT, 0.1%
bromophenol blue). Immunocomplexes were separated
on 10% SDS-polyacrylamide gel electrophoresis
(PAGE), transferred to polyvinylidene diﬂuoride
(PVDF) membrane (Millipore) and analyzed by western
blot using anti-AtCBP20, anti-AtCBP80, anti-AtHYL1
(Agrisera AS09530, AS09531, AS06136) or anti-FLAG
(Sigma) antibodies.
Protein pull-down assay
AtSE FL coding sequence and core fragment (core,
residues 194–543) were ampliﬁed using AtSEFLfor and
AtSEFLrev, AtSEcorefor and AtSEcorerev primers, re-
spectively (Supplementary Table S1), and cloned into the
pMalc4e plasmid. The plasmids were used for subsequent
transformation of Escherichia coli strain BL21(DE3)RIL.
Overexpression of FL and core fragment of SERRATE
fused with maltose binding protein (MBP) was performed
as follows: 2 h after induction by 0.4mM isopropyl b-D-1-
thiogalactopyranoside (IPTG), cells were harvested and
sonicated (15 cycles of 30 s ON and 30 s OFF; Bioruptor
Plus, Diagenode) in MBP buffer [20mM Tris–HCl, pH
7.4, 0.2mM NaCl, 1mM EDTA, protease inhibitor
tablets (Roche)]. After sonication, lysates were centrifuged
for 15min at 14 000g at 4C, and the supernatants con-
taining protein extract were collected. The same protocol
was carried out for MBP-GFP production. To obtain
AtCBP20, AtCBP80 and the TPR domains of the SGT1
protein, in vitro translation in the presence of [35S]-
methionine (HARTMANN ANALYTIC) was performed
using TNT T7 Coupled Wheat Germ Extract System
(Promega). For pull-down experiments, the MBP-AtSE
FL, MBP-AtSE core and MBP-GFP were bound to the
amylose resins (New England Biolabs), then washed three
times with MBP buffer and incubated with labeled
AtCBP20, AtCBP80 and TPR domains of SGT1 in phos-
phate buffer (28mM NaH2PO4, 72mM Na2HPO4,
250mM KCl and 0.5% Triton X-100) for 2 h at 4C.
Next, the resins were washed four times with phosphate
buffer, and protein complexes were eluted with 10mM
maltose. The labeled proteins were separated on 14%
SDS-PAGE and detected with an image analyzer (FLA-
5000, FUJIFILM).
RNA immunoprecipitation
For RIP experiments, the nuclear protein extract was
immunoprecipitated as described above. After washing
of the beads, co-precipitated RNAs were eluted from IP
samples with TRIZOL (Invitrogen). cDNA synthesis was
carried out with an oligo (dT)15 primer using Superscript
III reverse transcriptase (Invitrogen), according to the
manufacturer’s protocol. Ampliﬁcation was carried out
in 10 ml reaction mix containing 5 ml of Power SYBR
Green PCR Master Mix, 4 ml of 0.5 mM primers mix and
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1 ml of template. The qPCR was performed for 40 cycles
under the following cycling conditions: 95C for 10min,
40 cycles of 95C for 15 s, 60C for 1min (Applied
Biosystem 7900 HT thermocycler). Primers used for
qPCR are listed in Supplementary Table S1.
RNA isolation and high-resolution RT-PCR
Total RNA was isolated from 35-day-old rosette leaves
using the RNeasy Plant Mini Kit (Qiagen). RNA was ex-
tracted from three biological repeat samples for each line.
cDNA synthesis was carried out with an oligo (dT)15
primer using Superscript III reverse transcriptase
(Invitrogen), according to the manufacturer’s protocol.
The efﬁciency of cDNA synthesis was assessed by RT-
PCR ampliﬁcation of the ACT12 (At3g46520) cDNA
fragment. After ﬁrst-strand cDNA synthesis, 1 ml of the
cDNA template per reaction were used for each PCR
ampliﬁcation with gene/AS-speciﬁc oligonucleotide
primer pairs. Ampliﬁcation was carried out in a 25 ml
reaction mix containing 2.5 ml 10 PCR buffer with
MgCl2 (Roche), 4 ml nucleotide mix (1.25 mM of each
dNTP, Promega), 0.75 ml of combined primers (100mM
stock) and Taq DNA Polymerase (5U/ml, Roche). PCR
was performed for 24 cycles under the following condi-
tions: 94C for 2min, 24 cycles of 94C for 15 s, 50C
for 30 s, 72C for 1min and completed with 10min at
72C. AS-speciﬁc primers were designed to amplify the
expected alternatively spliced mRNA isoforms that were
selected based on either published AS events or taken
from ﬁve different Arabidopsis/plant bioinformatics data-
bases: ASIP (http://www.plantgdb.org/ASIP/EnterDB.
php), TIGR (http://www.tigr.org/tdb/e2k1/ath1/),
RIKEN (http://rarge.gsc.riken.jp/a_splicing/index.pl),
ASTRA (http://alterna.cbrc.jp/) and TAIR 7.0 (http://
www.arabidopsis.org/index.jsp) (46). The size of RT-
PCR products ranged between 60 and 700 bp. To visualize
the RT-PCR products on an ABI3730 capillary
sequencing machine (Applied Biosystems), each forward
primer was labeled with 6-carboxyﬂuoresceine. Splicing
and statistical analysis were performed as described previ-
ously (35). To validate statistical signiﬁcance of RIP
results, the t-Student’s test was used, and in the analyses
of AS comparisons, the hypergeometric test was used (31).
In both cases, P< 0.05 was applied for the validation.
RESULTS
SERRATE interacts with both subunits of AtCBC in the
cell nucleus
To analyze the subcellular localization of the A. thaliana
cap-binding protein complex, AtCBC, and the SERRATE
protein, AtSE, the two subunits of the nuclear CBC,
AtCBP20 and AtCBP80, were fused with enhanced
yellow ﬂuorescent protein (EYFP), and AtSE was fused
with enhanced cyan ﬂuorescent protein (ECFP) at the
N-termini for all proteins studied. The constructs were
transiently expressed in A. thaliana protoplasts. As
shown in Supplementary Figure S1 (top panel),
AtCBP20 co-localized with AtSE in the nucleus.
Co-localization between AtCBP80 and AtSE in the
nucleus was also detected, but AtCBP80 was also
present in the cytoplasm of transfected protoplasts
(Supplementary Figure S1, bottom panel). The cytoplas-
mic localization of AtCBP80 can be explained by rela-
tively low level of endogenous AtCBP20 in transfected
protoplasts, as the AtCBP20 is necessary for import of
AtCBP80 from the cytoplasm to the nucleus, as shown
by us previously (55). Taken together, our results
indicated that both components of AtCBC co-localize
with AtSE in the cell nucleus.
Next, we used BiFC to directly study the physical inter-
action between the proteins of the nuclear CBC and AtSE
in living plant cells. FL AtCBP20, AtCBP80 and AtSE
were fused to complementary nonﬂuorescent regions of
EYFP (52), and used for protoplast co-transfection
(Supplementary Table S2). As a positive control for the
BiFC experiment, we used AtCBP20 and AtCBP80 fused
to complementary parts of EYFP, and observed a strong
nuclear BiFC signal (Supplementary Table S2) conﬁrming
the interaction previously shown by Fluorescence
Resonance Energy Transfer (FRET) between the two
components of AtCBC (55). As a negative control, we
used plasmids containing EYFP fragments fused with N-
terminus or C-terminus of AtSE, AtCBP20 or AtCBP80
proteins in combination with free complementary EYFP
fragments (Figure 1, right panel; Supplementary Table
S2). However, in some protoplasts, a weak ﬂuorescence
signal was detected all over the transfected protoplast.
These interactions were most likely nonspeciﬁc owing to
unusually high expression levels of recombinant proteins.
Strong ﬂuorescence of reconstituted EYFP was
observed in protoplasts co-transfected with combinations
of BiFC vectors containing sequences of AtSE and
AtCBP80 or AtSE and AtCBP20 (Figure 1, left and
middle panels). In both cases, the ﬂuorescence in most
Figure 1. BiFC analysis of the interaction between AtCBC subunits
and AtSE. Arabidopsis thaliana protoplasts were co-transfected with
combinations of different plasmids encoding EYFP or cEYFP fused
to AtSE, AtCBP20 and AtCBP80 coding sequences. Insets represent
a magniﬁed view of the representative nucleus for each interaction.
The lower panel shows transmission images of the transfected proto-
plasts in which ﬂuorescence was observed (upper panel). Scale
bars=20 mm.
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cell nuclei was not homogenous, and several brighter spots
were observed in the nucleoplasm of 90% nuclei of cells
co-transfected with AtCBP20 and AtSE, and in 70% of
the nuclei transfected with plasmids coding AtCBP80 and
AtSE (Supplementary Figure S2 and Supplementary
Table S2). The observation that AtSE binds both
AtCBP20 and AtCBP80 are in contrast to the results
recently published by Wang et al. (2013) (57), which did
not detect an interaction between AtSE and the larger
subunit of CBC either in BiFC or in pull-down experi-
ments. Although we showed the interaction between
AtSE and both AtCBC subunits (above), this interaction
was not seen in all conformations of plasmids used in
BiFC (see Supplementary Table S2). For example, the
AtSE fused at the C terminus with the C-terminal
fragment of EYFP did not give a signal when co-trans-
fected with AtCBP80 fused with N-terminal fragment
of EYFP. Therefore, we conﬁrmed our observation with
independent methods: protein pull-downs and co-
immunoprecipitation. For the protein pull-down assays
(Figure 2), we analyzed the interactions between [35S]-
methionine-labeled AtCBP20, AtCBP80 and the TPR
domains of the SGT1 protein with full length (FL) or
the core domain of AtSE fused with the MBP. No inter-
actions were observed when negative controls (TPR
domains of the SGT1 or MBP-fused GFP) were added
to the sample (Figure 2, lane 5–7, 14, 15). However, we
detected a signal conﬁrming the interaction with AtSE
when AtCBP20 and/or AtCBP80 were added to the
sample either separately or together (Figure 2, lane 8–11
and 12, 13, respectively). Both CBP subunits bind to the
FL AtSE protein as well as to the AtSE core; the core
fragment of AtSE acts as a protein-binding platform
(58). Interestingly, the binding of the AtCBP20 with
AtSE seems to be stronger than AtCBP80 with AtSE,
and the strongest interaction was observed when
AtCBP20 and AtCBP80 interact with AtSE in a
complex (Figure 2, line 12, 13). The stronger signal
shown by AtCBP20 may be the result of a higher efﬁciency
pull-down, as a result of better folding of the smaller
subunit of AtCBC.
As mentioned above, Wang et al. (2013) (57) did not
observe the interaction between AtSE and atCBP80 in
pull-down experiments. However, as they have not
shown that the recombinant AtCBP80 protein is able to
bind AtCBP20, we suggest their negative result might
come from incorrectly folded AtCBP80 protein used in
their analyses.
We also performed a co-immunoprecipitation
experiment with the nuclear protein lysate extracted
from plants overexpressing either AtSE:FLAG or
AtHYL1:FLAG proteins (Figure 3B). The latter was
Figure 2. The interaction between FL AtSE or its core fragment (residues 194–543; AtSE core), and AtCBP20 and/or AtCBP80. AtSE FL, AtSE
core and GFP proteins were overexpressed in bacteria in fusion with MBP; AtCBP20, AtCBP80 and TPRSGT1 (used as a negative control) were
synthesized in the presence of [35S]-methionine (an asterisk in the protein name abbreviation means that the protein was labeled). The complexes were
selected on amylose beads, separated on 14% SDS-PAGE and detected by exposure to an image analyzer. Inputs represent one-twentieth of the
samples used in the experiment.
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used as a negative control: according to our previous ob-
servation, the AtHYL1 protein does not interact directly
with AtCBP20 and AtCBP80 (55). Western blot analyses
with anti-AtCBP80 and anti-AtCBP20 antibodies revealed
the presence of both proteins in the fraction co-
immunoprecipitated with SERRATE but not with
HYL1 (Figure 3B), conﬁrming the AtCBC/AtSE inter-
action in plant cells. Similar to the pull-down experiments,
in the western blot performed after co-immunopre-
cipitation, we did observe stronger signal from AtCBP20
then AtCBP80, although both CBC subunits were
detected in the immunoprecipitates analyzed (Figure 3B,
bottom panel). Taken together, the BiFC analyses per-
formed in protoplasts as well as pull-down and
immunoprecipitation experiments indicated that in A.
thaliana both AtCBC subunits form a complex with
AtSE. Moreover, the AtCBC/AtSE complex seems to be
localized exclusively in the nucleus where it is dispersed
within the nucleoplasm or accumulated in several distinct
subnuclear regions.
AS is affected in the Arabidopsis se-1 mutant
The subunits of the A. thaliana nuclear cap-binding
protein complex, AtCBP20 and AtCBP80, as well as the
SERRATE protein are involved in both miRNA biogen-
esis and pre-mRNA splicing (36,40–45). We have recently
shown that the nuclear cap-binding protein complex
(AtCBC) is also directly involved in AS of some
Arabidopsis genes, and in most cases the AtCBC inﬂu-
ences 50 splice site selection of ﬁrst introns (35). As the
AtSE participates in pre-mRNA splicing and interacts
with AtCBC (Figures 1–3), we asked whether
SERRATE is also involved in the regulation of AS in
plants. To answer this question, we used the high-reso-
lution RT-PCR AS panel (46) containing a set of
primers designed to examine 302 AS events in 285
Arabidopsis genes. These genes encode mainly transcrip-
tion factors, splicing factors and stress-related proteins
(for the full list see 35). The panel included a range of
different types of AS events: alternative 50 or 30 splice
site selection, alternative position (50 and 30 splice sites
altered in the same splicing event), exon skipping and
intron retention. Splicing proﬁles were determined for
wild-type Col-0 and the se-1 mutant, and the ratio of
the alternatively spliced products for each gene was
compared. Means and standard errors were calculated
for three separate independent experiments.
Signiﬁcant changes (>3%; P< 0.10) in the ratios of AS
isoforms in the se-1 mutant, in comparison with the wild-
type plant, were found in 78 AS events (in 67 genes)
(Table 1). To identify whether introns or AS events in
particular positions in the transcripts were inﬂuenced pref-
erentially by the AtSE protein, we compared the genes
Figure 3. The interaction between AtSE and AtCBC. (A) Western blot analysis using anti-FLAG and anti-AtHYL1 antibodies conﬁrmed the
presence of AtSE:FLAG (left panel) and AtHYL1:FLAG (right panel) in two different lines of transformed se-1 (L1 and L2) and hyl1-2 (L1
and L2) mutant plants, respectively. (B) AtCB20 (top panel) and AtCBP80 (bottom panel) were detected by western in complexes co-immunopre-
cipitated with anti-FLAG antibodies from transgenic plants expressing AtSE:FLAG, but not from plants expressing AtHYL1:FLAG. Transgenic
lines L1 and L2 were used in the case of plants expressing AtSE:FLAG and AtHYL1:FLAG, respectively. The position of the closest protein marker
is indicated on the left; an asterisk marks an unidentiﬁed protein cross-reacting with anti-FLAG antibodies.
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with signiﬁcantly changed AS proﬁles in the se-1 mutant
to all analyzed genes from the high-resolution RT-PCR
AS panel. In se-1, the changes involved mainly AS events
located within internal introns (42 events, 54%) and ﬁrst
introns (29 events, 37%), with only seven cases of an AS
event located within the last introns (7 events, 9%)
(Figure 4A). Similarly, of the 302 AS events on the
panel, 108 (36%) events were in the ﬁrst intron, 135
(45%) events were in internal introns and 59 (19%)
events were in the last intron (Figure 4A). In the se-1
mutant, the signiﬁcantly changed AS events included
mostly changes in alternative 30 or 50 splice sites (29 and
23 events, 37 and 29%, respectively), but also included
intron retention (14 events, 18%) and exon skipping (8
events, 10%) (Figure 4B). In contrast, alternative 30 and
50 splice sites among all of the AS events/genes on the RT-
PCR panel accounted for 46 and 24% of the total, respect-
ively (Figure 4B). This reﬂects the fact that AS in plants
occurs more frequently at alternative acceptor sites (30
splice sites) than in 50 donor sites (22 versus 10%) (6,15).
Thus, in the se-1 mutant, there was an increased number
of genes with signiﬁcant changes at alternative 50 splice
sites than in the overall AS events analyzed. When we
looked at the distribution of different AS events within
ﬁrst and internal introns, we found that in the se-1
mutant AS within ﬁrst introns was mostly affected at the
50 splice site (45%), while AS within internal introns was
mostly affected at the 30 splice site (43%) (Figure 4C).
Thus, AtSE preferentially inﬂuences AS of the ﬁrst
intron of a pre-mRNA at alternative 50 splice sites.
To conﬁrm the regulatory role of AtSE in AS of
Arabidopsis gene transcripts, we checked whether AtSE
can directly bind selected target transcripts. Using the
transgenic plants overexpressing the FLAG-tagged AtSE
protein, we performed immunoprecipitation using anti-
FLAG antibodies followed by subsequent isolation of
bound RNAs and reverse transcription. qPCR was per-
formed on six arbitrarily chosen genes whose AS proﬁle
was changed in the se-1mutant (Supplementary Table S1).
The results revealed that AtSE co-immunoprecipitates
four of six transcripts analysed, suggesting that
SERRATE can directly bind those mRNAs (Figure 5).
No binding was observed in the case of one intron-less
mRNA (At5g16370) used in this experiment as a
negative control. Thus, the role of SERRATE as a regu-
lator of AS of selected gene transcripts in A. thaliana was
conﬁrmed.
AtSE and AtCBC cooperate in regulation of AS of some
genes
The preference of the AtSE protein in affecting AS at
alternative 50 splice sites within ﬁrst introns resembles
our previous observations of the cbp20, cbp80(abh1)
and cbp20/80 double mutants (35). As AtCBP20 and
AtCBP80 both interact with AtSE, we asked whether the
AS proﬁles observed in the se-1 mutant were similar to
those observed previously in the cbp mutants. Of the 67
genes with signiﬁcant changes in AS proﬁle in the se-1
mutant, 22 also had signiﬁcant changes in AS in the cbp
mutants (35) (Table 1).
A
B
C
108
135
59
29
42
7
0
10
20
30
40
50
60
first intron internal intron last intron
%
 o
f A
S 
ev
en
ts
AS introns
all analyzed AS 
events
AS events 
changed in se-1
137
71
32
56
6
29
23
8
14
4
0
5
10
15
20
25
30
35
40
45
50
3'SS 5'SS ES IR AltP
%
 o
f A
S 
ev
en
ts
AS events
all analyzed AS 
events
AS events 
changed in se-1
48
33
10
15
2
9
13
3
2 2
0
10
20
30
40
50
3'SS 5'SS ES IR AltP
first intron
all analyzed AS 
events
AS events 
changed in se-1
65
20 20
27
3
18
6
4
12
2
0
10
20
30
40
50
60
3'SS 5'SS ES IR AltP
internal intron
all analyzed AS 
events
AS events 
changed in se-1
24
18
2
14
1
2
4
1
0 0
0
10
20
30
40
50
60
3'SS 5'SS ES IR AltP
%
 o
f A
S 
ev
en
ts
last intron
all analyzed AS 
events
AS events 
changed in se-1
Figure 4. Distribution of the AS events presented for the total AS
events (302 events/285 genes, gray bars), and those that changed in
the se-1 mutant (78 events/67 genes, black bars). (A) Distribution of
the position of the alternatively spliced introns (ﬁrst intron, internal
intron, last intron); (B) Distribution of the alternatively spliced
events: alternative 30 splice site (30SS), alternative 50 splice site (50SS),
exon skipping (ES), intron retention (IR), alternative 30 and 50 splice
sites (AltP); (C) Distribution of the AS events within ﬁrst introns,
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number of alternatively spliced events. Statistical signiﬁcance was
tested using the hypergeometric test; an asterisk marks signiﬁcant
changes (P< 0.05).
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Of the 22 AS events, which were affected in both the se-
1 and cbp mutants, 19 showed the same direction of AS
changes (Table 1). The majority of these genes showed
signiﬁcant AS changes in the se-1 and the double cbp20/
cbp80 mutant (18 genes), and 12 of these showed signiﬁ-
cant differences in the se-1 and all three cbp mutants
(Table 1). Two genes (primer pair 102: At1g27370, and
225: At3g53570) showed the same direction of AS
splicing in the se-1 mutant, the double cbp20/cbp80
mutant and cbp80(abh1) or cbp20, respectively. One
gene (305; At1g01060) showed the same direction in the
se-1 and cbp80(abh1) mutants. It is important to note that
in the cbp80(abh1) mutant the level of AtCBP20 is ex-
tremely low, and is therefore to all extents and purposes
similar to the double cbp20/cbp80 mutant (55).
Furthermore, among the 19 genes with common changes
in the se-1 and cbpmutants, the AS events were located for
the most part within the ﬁrst intron (12 of 19) (Table 1,
boxed). Of these 12, six of the AS events were alternative
50 splice sites (Table 1, shaded gray). Thus, almost a third
(19/67) and a ﬁfth (19/101) (35) of the signiﬁcantly
changed AS events in the se-1 and cbp mutants, respect-
ively, were common, and showed a similar behavior in AS,
suggesting that both AtSE and AtCBP80/CBC are
required for AS of the genes studied. As we showed pre-
viously for AtCBC, we did not observe any preference for
selection of either cap-proximal or cap-distal alternative 50
splice sites within the ﬁrst introns. On the other hand, we
did observe some inﬂuence on intron retention AS events
(Table 1 and Figure 4B and C). However, we did not
detect in our panel any signiﬁcant inﬂuence on the levels
of unspliced transcripts that might reﬂect an effect on
general splicing efﬁciency in the se-1 mutant.
In addition, 45 genes (54 AS events) showed signiﬁcant
changes in AS proﬁles in the se-1 mutant exclusively.
For these genes, we did not observe any enrichment of
AS events within ﬁrst introns (16 events in ﬁrst introns
versus 38 events in internal and last introns) (Table 1).
Thus, neither AtCBC nor AtSE seems to inﬂuence the
general efﬁciency of splicing, but both factors participate
in AS of some genes. The interaction between AtCBP80
and AtSE along with the preferential effects on the ﬁrst
intron and alternative 50 splice site suggests that at least
for some transcripts there is mutual cooperation of AtSE
with the nuclear CBC in determining splice site choice.
However, these factors also affect the AS of different
subsets of genes and therefore can act independently in
AS regulation.
AS is also affected by other proteins involved in plant
miRNA biogenesis
AtSE along with CBPs affect AS of a subset of genes pu-
tatively reﬂecting the interaction between SE and the cap
binding complex (Figures 1–3), and recruitment of other
splicing factors. Why and how SERRATE, which is
mainly involved in miRNA biogenesis, affects AS of
other genes independently is unknown. We therefore
examined AS in mutants of other miRNA processing
pathway factors that are known to interact with SE:
HYL1 and DCL1. The hyl1-2 mutant is a T-DNA inser-
tion mutant with no production of the HYL1 protein (47),
and dcl1-7 has a point mutation in the DCL1 gene
encoding the endonuclease directly involved in miRNA
biogenesis; the dcl1-7 mutant was used in the studies
since the T-DNA inactivation of the DCL1 gene is lethal
(49). To address the question of whether mutations in
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Figure 5. Interactions of AtSE with selected mRNA targets detected by RIP. Immunoprecipitation followed by RNA isolation and RT-qPCR
conﬁrmed in vivo interactions of AtSE:FLAG with candidate gene transcripts whose AS proﬁle was changed in the se-1 mutant; intron-less mRNA
was used as a negative control (At5g16370). The level of transcripts co-precipitated from transgenic plant expressing AtSE:FLAG (IP+) or wild type
plants (mock) using anti-FLAG antibodies were normalized to the inputs. Means±SD are presented based on three biological replicates; statistical
signiﬁcance was tested using the t-Student’s test; an asterisk marks signiﬁcant changes (P< 0.05).
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DCL1 and HYL1 genes affected AS, and whether the
effects resembled those of the se-1 mutant, we again
used the high-resolution RT-PCR panel to analyze AS
events in hyl1-2 and dcl1-7 mutants.
Of the 285 analyzed genes, we found signiﬁcant changes
in the ratios of AS isoforms in 122 genes in the se-1, hyl1-2
and dcl1-7 mutants, in comparison with wild type plants
(Table 2). Of these 122 genes, 33 were observed exclusively
in the se-1 mutant, and 32 and 14 genes showed signiﬁcant
AS changes only in the dcl1-7 or hyl1-2 mutant, respect-
ively. Interestingly, nine genes showed signiﬁcant changes
in AS in all three miRNA biogenesis mutants tested, while
nine genes had changes in the hyl1-2 and dcl1-7 mutants,
12 in the hyl1-2 and se-1 mutants and 13 in the se-1 and
dcl1-7 mutants (Figure 6A and Table 2).
Of the 33 genes affected only in the se-1 mutant, 17 AS
events were located within the ﬁrst intron, and eight of
them affected alternative 50 splice sites (Figure 6B and
C). Moreover, 13 of the 33 genes with signiﬁcant AS
changes observed in the se-1 mutant also occurred in the
cbp mutants, conﬁrming our previous conclusion that the
nuclear CBC and the SERRATE protein cooperate in se-
lection of 50 splice sites of some pre-mRNA ﬁrst introns
(Table 2, shaded gray, Figure 7). In the other miRNA
biogenesis mutants we did not observe an enrichment of
AS changes in introns located closest to the cap. This is
illustrated by analyzing the 122 genes with AS changes in
either se-1, dcl1-7 or hyl1-2. Although 48 of these genes
had signiﬁcant AS changes in the ﬁrst intron (Figure 6B
and Table 2), only 14 affected selection of alternative 50
splice sites (Figure 6C and Table 2). Twelve of these
involved the se-1 mutant with eight only in the se-1
mutant, and two common to the se-1 and dcl1-7
mutants. Thus, the predominant effect of AS on alterna-
tive 50 splice site selection at the ﬁrst intron seen in the cbp
and se-1 mutants is not observed for the AS events
affected in dcl1-7 or hyl1-2. As a result, SE and CBC,
which interact and associate with the cap structure, have
clearly distinct effects on AS from DCL1 and HYL1.
DISCUSSION
AtSE is a novel factor involved in AS regulation
Previously we have shown that the plant nuclear CBC,
consisting of two subunits, AtCBP20 and AtCBP80, inﬂu-
ences AS, preferentially affecting AS of the ﬁrst intron at
the 50 splice site (35), and this has since been also
demonstrated in human cells (59). Here, we introduce
another plant AS factor, SERRATE (AtSE), that acts in
a similar way to CBC, mostly affecting selection of alter-
native 50 splice sites within the intron that is the closest to
the cap structure. The role of AtSE as a plant splicing
factor was suggested previously when some unspliced
intron-retaining pre-mRNAs were observed in A.
thaliana se-1, cbp80(abh1) and cbp20 mutants by micro-
array analysis (43). Signiﬁcantly, in the few identiﬁed
cases, splicing of the ﬁrst intron seemed to be most sensi-
tive to loss of either AtCBC or AtSE activity, suggesting
that both CBC and AtSE inﬂuence splicing of plant pre-
mRNAs in a similar manner (43). In this study, we have
Figure 6. Distribution of AS events with signiﬁcant changes in AS proﬁles in the se-1, hyl1-2 and dcl1-7 mutants (A) in total, (B) within ﬁrst introns,
(C) within ﬁrst introns at the 50 splice sites.
Figure 7. Distribution of AS events with signiﬁcant changes in AS proﬁles in se-1, hyl1-2, dcl1-7 compared with the all cbp mutants (A) in total;
(B) within ﬁrst introns; (C) within ﬁrst introns at the 50 splice sites.
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shown that AtSE affects AS, and that in many cases
(28%) the changes of AS observed in the se-1 mutant
were similar to the changes observed previously in the
cbp mutants. This suggests that for at least some genes,
AS can be regulated coordinately by the nuclear CBC and
AtSE. Such coordination could reﬂect a direct interaction
between AtCBC and AtSE; we have shown here that both
components of AtCBC co-localize with AtSE in the
nucleus, and interestingly, both AtCBC subunits,
AtCBP20 and AtCBP80, interact with AtSE in vitro and
in planta. A similar interaction has been seen in human
where the nuclear CBC interacts with the human
SERRATE homolog—Ars2 (Arsenic Resistance Protein
2). In this case, immunoprecipitation of FLAG-Ars2 con-
ﬁrmed that Ars2 co-precipitates both the 80 and 20 kDa
subunits of the human CBC (60). Additionally, AtSE was
also identiﬁed in nuclear speckles in which SR splicing
factors were enriched (61), and Ars2 was identiﬁed as a
component of RNA–protein complexes enriched for
spliceosomes (60), again potentially reﬂecting a role in
splicing/AS.
Besides the AS changes common to both the se-1 and
cbp mutants, AtSE inﬂuenced AS of other genes.
Previously, unspliced or pre-mRNAs with retained
introns were observed for the se-1 and cbp mutants (43).
While this might suggest a general effect on splicing efﬁ-
ciency, it more likely reﬂects the resolution of microarrays,
and we show that loss of AtCBC and AtSE does not affect
splicing/AS of all introns but rather both factors prefer-
entially participate in the selection of the 50 splice site of
the ﬁrst intron.
Involvement of AtSE and AtCBC in miRNA biogenesis
The main function of AtSE in plants is in the miRNA
biogenesis pathway (36,40,41). Owing to its signiﬁcant
role in this process, a null mutation of the SE gene is
lethal (40), and nonlethal mutants (e.g. se-1) lead to pleio-
tropic developmental defects with increased cauline leaf
number, serrated leaf morphology and hypersensitivity
to abscisic acid (ABA) (36,37). A similar but less severe
phenotype is observed in Arabidopsis mutants of CBP20
and/or CBP80(ABH1) (37–39), suggesting that the role of
both CBC subunits in plant miRNA biogenesis (43–45) is
not as critical as that of AtSE, since the lack of both CBC
subunits has only limited effects on the mutant phenotype
(35,62–64). The CBC is thought to bind the capped pri-
miRNA transcripts, and facilitate the loading of the
miRNA processing machinery onto pri-miRNAs, analo-
gous to its role in recruiting the splicing commitment
complex onto pre-mRNAs (43–45). AtSE is thought to
connect the CBC and miRNA processing machinery as
it binds both AtCBC (Figures 1–3) and DCL1 or HYL1
as has been previously demonstrated (41,65).
AtCBP80(ABH1) and AtSE also work together in
splicing-mediated suppression of RNA silencing in
Arabidopsis (66,67) again demonstrating the collabor-
ation between these two proteins in RNA processing
pathways. In human cells, Ars2 (the human homologue
of SERRATE) and CBP80 co-precipitate with Drosha,
and the depletion of CBP20 and CBP80, and of Ars2,T
a
b
le
2
.
C
o
n
ti
n
u
ed
P
ri
m
er
p
a
ir
G
en
e
ID
A
n
n
o
ta
ti
o
n
In
tr
o
n
A
S
ty
p
e
W
il
d
ty
p
e
-
C
o
l0
se
-1
P

0
.1
h
y
l1
-2
P

0
.1
d
cl
1
-7
P

0
.1
3
7
3
A
t3
g
1
3
2
2
4
R
N
A
re
co
g
n
it
io
n
m
o
ti
f
(R
R
M
)-
co
n
ta
in
in
g
p
ro
te
in
5
(l
a
st
)
IR
0
.7
1
±
0
.0
2
0
.7
8
±
0
.0
2
0
.0
3
0
0
.2
9
±
0
.0
2
0
.2
2
±
0
.0
2
0
.0
2
3
3
2
8
A
t5
g
5
2
3
1
0
D
es
si
ca
ti
o
n
-r
es
p
o
n
si
v
e
p
ro
te
in
(R
D
2
9
A
)
(C
O
R
7
8
);
re
sp
o
n
se
to
co
ld
,
o
sm
o
ti
c,
sa
li
n
it
y
,
d
es
si
ca
ti
o
n
,
A
B
A
st
im
u
lu
s
4
(l
a
st
)
A
lt
P
0
.4
4
±
0
.1
2
0
.7
7
±
0
.0
3
0
.0
9
3
0
.4
8
±
0
.1
3
0
.1
5
±
0
.0
5
0
.0
8
6
S
ig
n
iﬁ
ca
n
t
ch
a
n
g
es
in
A
S
is
o
fo
rm
a
b
u
n
d
a
n
ce
in
th
e
se
-1
,
h
y
l1
-2
,
d
cl
1
-7
m
u
ta
n
ts
,
w
h
ic
h
a
re
a
ls
o
o
b
se
rv
ed
in
cb
p
m
u
ta
n
ts
(3
2
)
a
re
sh
a
d
o
w
ed
b
y
g
ra
y
.
T
h
e
ta
b
le
co
n
ta
in
s
o
n
ly
is
o
fo
rm
s
th
a
t
ch
a
n
g
ed
si
g
n
iﬁ
ca
n
tl
y
(>
3
%
;
P

0
.1
).
Nucleic Acids Research, 2014, Vol. 42, No. 2 1241
 at U
niversity of D
undee on June 20, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
results in similar defects in miRNA formation and
miRNA-mediated silencing (60). In Drosophila, Ars2 and
CBC are also required for miRNA function, Ars2
and Dicer-2 interact and Ars2 is involved in processing
of dsRNAs into siRNA by Dicer-2 (68). As this pro-
cess occurs in the cytoplasm, it suggests that the
activity of Ars2 is not restricted only to the nucleus (68).
Taken together, in several species, the SERRATE
homologues appear to function as a bridging factor
that co-transcriptionally binds CBC that is associated
with the 50 end of a pri-miRNA transcript, and recruits
miRNA processing components to the substrate, hence
increasing both the efﬁciency and precision of miRNA
processing.
AS in the mutants of miRNA biogenesis
The se-1 mutant affected AS of a number of genes
including a subset also affected by the CBC. The effect
of AtSE on splicing can be explained by its interaction
with the CBC on pre-mRNAs or, if it links the CBC to
splicing factors/spliceosomal proteins, it is possible that it
can also interact with such proteins independently of the
cap to inﬂuence splicing. There are a number of other
potential mechanisms by which AS could be affected in
the se-1 mutant through indirect effects of disruption of
the plant miRNA biogenesis pathway. For example, a
miRNA could target and degrade speciﬁc alternatively
spliced transcript isoforms as has already been reported
(69), and reduced production of the miRNA would affect
the relative levels of isoforms. Alternatively, AS can affect
the production of intronic miRNAs (70). We therefore
also examined AS in the hyl1-2 and dcl1-7 mutants in
addition to se-1. Surprisingly, all three mutants showed
altered AS in a number of genes, although only nine
genes had similar changes in AS proﬁle common to all
three mutants. These may reﬂect changes due to disrup-
tion of miRNAs, but so far only two of the genes are
known targets of miRNAs. However, if plant miRNAs
have a wider target range or off target effects than cur-
rently known, this might explain the impact on AS. The
three mutants also affected AS of some genes uniquely.
HYL1 is crucial for processing of only a subset of pre-
miRNAs (47,71), which may explain the speciﬁc effect on
particular genes. Disrupted interactions in the SE-HYL1-
DCL1 complex may also affect miRNA biogenesis. For
example, the hyl1-2 mutant is a null T-DNA insertion
mutant of HYL1 (71) but an amino acid substitution in
the ATPase/DExH-box RNA helicase domain of DCL1
confers restoration of miRNA expression in the hyl1-2
mutant background, implying that HYL1 may not be
even required for miRNA processing (72). The interaction
with HYL1 triggers structural rearrangements of DCL1
that activates its RNase III domain normally repressed
by the helicase domain, similarly to human Dicer that is
autoinhibited by its helicase domain, but can be activated
by interaction with TRBP2 (73,74). Thus, in the hyl1-2
mutant, the activity of DCL1 can be altered potentially
affecting levels of some miRNAs. AtDCL1 is also
involved in production of some siRNAs, which could
also affect AS transcript isoform levels via degradation
of targets or through methylation of DNA causing
altered rates of transcription and subsequent changes in
splice site selection (75). The effects of the se-1, hyl1-2 and
dcl1-7mutants on AS may also be due to altered transcript
levels of genes encoding proteins involved in transcription,
splicing or transport. Recently, HYL1 was shown to
interact by its double-stranded RNA-binding (DRB)
domain with other secondary structured RNAs, like trans-
posons, recognizing structured RNA fragments, especially
those with imperfect stem-and-loop structures (76). This
raises the further possibility that HYL1 can also bind to
regions of pre-mRNAs that form secondary structures,
which could inﬂuence the recognition of acceptor or
donor sites by splicing factors, resulting in alteration of
constitutive splicing. On the other hand, in the absence of
HYL1, DCL1 can associate with other DRB proteins, and
is also capable of cleaving RNA hairpin structures,
although in such cases the DCL1 endonuclease predomin-
antly processes the substrate incorrectly (77). This could
lead to production of incorrect small RNA molecules that
could erroneously target other mRNAs/alternative
isoforms for cleavage.
In summary, we observed changes in AS of transcripts
in mutants of the miRNA biogenesis pathway, and while
some of those affected in se-1 can be explained owing to its
interaction with the CBC, the reasons for the AS effects
of the hyl1 and dcl1 mutants are not clear, and system-
atic experiments are needed to address this intriguing
question.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The authors would like to thank Aleksandra Zulsdorff for
help in statistical analyses, Szymon Tylewicz and Anna
Mrozinska for help in preparation of BiFC vectors,
Michal Taube for providing vector carrying TPRSGT1
coding sequence, and Jakub Dolata for providing
starters used for the At5g16370 transcript detection in
RIP. The authors also thank Paul Zalesky for critical
reading of the manuscript, and correcting language errors.
FUNDING
Polish National Science Center [UMO-2011/01/M/NZ2/
01435 to A.J. UMO-2012/05/N/NZ2/00880 to A.S. and
UMO-2012/04/NZ2/00127 to Z.S.-K.]; the Polish
Ministry of Science and Higher Education [4631/B/PO1/
2010/39 to M.K.]; Biotechnology and Biological Sciences
Research Council (BBSRC) [BB/G024979/1 - European
Research Area network (ERA-NET) Plant Genomics
(Plant Alternative Splicing and Abiotic Stress)]; Scottish
Government Rural and Environment Science and
Analytical Services division (RESAS). Funding for open
access charge: Polish National Science Center [grant
UMO-2011/01/M/NZ2/01435]; Adam Mickiewicz
University, Faculty of Biology, Poznan, Poland.
1242 Nucleic Acids Research, 2014, Vol. 42, No. 2
 at U
niversity of D
undee on June 20, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Conﬂict of interest statement. None declared.
REFERENCES
1. Pan,Q., Shai,O., Lee,L.J., Frey,B.J. and Blencowe,B.J. (2008)
Deep surveying of alternative splicing complexity in the human
transcriptome by high-throughput sequencing. Nat. Genet., 40,
1413–1415.
2. Wang,E.T., Sandberg,R., Luo,S., Khrebtukova,I., Zhang,L.,
Mayr,C., Kingsmore,S.F., Schroth,G.P. and Burge,C.B. (2008)
Alternative isoform regulation in human tissue transcriptomes.
Nature, 456, 470–476.
3. Filichkin,S.A., Priest,H.D., Givan,S.A., Shen,R., Bryant,D.W.,
Fox,S.E., Wong,W.K. and Mockler,T.C. (2010) Genome-wide
mapping of alternative splicing in Arabidopsis thaliana. Genome
Res., 20, 45–58.
4. Marquez,Y., Brown,J.W.S., Simpson,C.G., Barta,A. and
Kalyna,M. (2012) Transcriptome survey reveals increased
complexity of the alternative splicing landscape in Arabidopsis.
Genome Res., 22, 1184–1195.
5. Black,D.L. (2003) Mechanisms of alternative pre-messenger RNA
splicing. Annu. Rev. Biochem., 72, 291–336.
6. Wang,B.B. and Brendel,V. (2006) Genome-wide comparative
analysis of alternative splicing in plants. Proc. Natl Acad. Sci.
USA, 103, 7175–7180.
7. Stamm,S., Ben-Ari,S., Rafalska,I., Tang,Y., Zhang,Z., Toiber,D.,
Thanaraj,T.A. and Soreq,H. (2005) Function of alternative
splicing. Gene, 344, 1–20.
8. Syed,N.H., Kalyna,M., Marquez,Y., Barta,A. and Brown,J.W.
(2012) Alternative splicing in plants-coming of age. Trends Plant
Sci., 17, 616–623.
9. Pan,Q., Saltzman,A.L., Kim,Y.K., Misquitta,C., Shai,O.,
Maquat,L.E., Frey,B.J. and Blencowe,B.J. (2006) Quantitative
microarray proﬁling provides evidence against widespread
coupling of alternative splicing with nonsense-mediated decay to
control gene expression. Genes Dev., 20, 153–158.
10. Ni,J.Z., Grate,L., Donohue,J.P., Preston,C., Nobida,N.,
O’Brien,G., Shiue,L., Clark,T.A., Blume,J.E. and Ares,M. (2007)
Ultraconserved elements are associated with homeostatic control
of splicing regulators by alternative splicing and nonsense-
mediated decay. Genes Dev., 21, 708–718.
11. Campbell,M.A., Haas,B.J., Hamilton,J.P., Mount,S.M. and
Buell,C.R. (2006) Comprehensive analysis of alternative splicing
in rice and comparative analyses with Arabidopsis. BMC
Genomics, 7, 327–343.
12. Lewis,B.P., Green,R.E. and Brenner,S.E. (2003) Evidence for the
widespread coupling of alternative splicing and nonsense-mediated
mRNA decay in humans. Proc. Natl Acad. Sci. USA, 100,
189–192.
13. Kalyna,M., Simpson,C.G., Syed,N.H., Lewandowska,D.,
Marquez,Y., Kusenda,B., Marshall,J., Fuller,J., Cardle,L.,
McNicol,J. et al. (2011) Alternative splicing and nonsense-
mediated decay modulate expression of important regulatory
genes in Arabidopsis. Nucleic Acids Res., 40, 2454–2469.
14. Ner-Gaon,H., Halachmi,R., Savaldi-Goldstein,S., Rubin,E.,
Ophir,R. and Fluhr,R. (2004) Intron retention is a major
phenomenon in alternative splicing in Arabidopsis. Plant J., 39,
877–885.
15. Reddy,A.S.N. (2007) Alternative splicing of pre-messenger RNAs
in plants in the genomic era. Annu. Rev. Plant Biol., 58, 267–294.
16. Graveley,B.R. (2001) Alternative splicing: increasing diversity in
the proteomic world. Trends Genet., 17, 100–107.
17. Blencowe,B.J. (2006) Alternative splicing: new insights from
global analyses. Cell, 126, 37–47.
18. Baek,J.M., Han,P., Iandolino,A. and Cook,D.R. (2008)
Characterization and comparison of intron structure and
alternative splicing between Medicago truncatula, Populus
trichocarpa, Arabidopsis and rice. Plant Mol. Biol., 67, 499–510.
19. Barbazuk,W.B., Fu,Y. and McGinnis,K.M. (2008) Genome-wide
analyses of alternative splicing in plants: opportunities and
challenges. Genome Res., 18, 1381–1392.
20. Simpson,C.G., Lewandowska,D., Fuller,J., Maronova,M.,
Kalyna,M., Davidson,D., McNicol,J., Raczynska,D.,
Jarmolowski,A., Barta,A. et al. (2008) Alternative splicing in
plants. Biochem. Soc. Trans., 36, 508–510.
21. Kalyna,M., Lopato,S., Voronin,V. and Barta,A. (2006)
Evolutionary conservation and regulation of particular alternative
splicing events in plant SR proteins. Nucleic Acids Res., 34,
4395–4405.
22. Wang,B.B. and Brendel,V. (2004) The ASRG database:
identiﬁcation and survey of Arabidopsis thaliana genes involved in
pre-mRNA splicing. Genome Biol., 5, R102.
23. Ru,Y., Wang,B.B. and Brendel,V. (2008) Spliceosomal proteins in
plants. In: Reddy,A.S.N. and Golovkin,M. (eds), Nuclear Pre-
mRNA Processing in Plants, Vol. 326. Springer, Heidelberg,
pp. 1–15.
24. Palusa,S.G., Ali,G.S. and Redddy,A.S.N. (2007) Alternative
splicing of pre-mRNAs of Arabidopsis serine/arginine-rich
proteins and its regulation by hormones and stresses. Plant J., 49,
1091–1107.
25. Isshiki,M., Tsumoto,A. and Shimamoto,K. (2006) The serine/
arginine-rich protein family in rice plays important roles in
constitutive and alternative splicing of pre-mRNA. Plant Cell, 18,
146–158.
26. Lopato,S., Kalyna,M., Dorner,S., Kobayashi,R., Krainer,A.R.
and Barta,A. (1999) atSRp30, one of two SF2/ASF-like proteins
from Arabidopsis thaliana, regulates splicing of speciﬁc plant
genes. Genes Dev., 13, 987–1001.
27. Kalyna,M., Lopato,S. and Barta,A. (2003) Ectopic expression of
atRSZ33 reveals its function in splicing and causes pleiotropic
changes in development. Mol. Biol. Cell, 14, 3565–3577.
28. Sureau,A., Gattoni,R., Dooghe,Y., Ste´venin,J. and Soret,J. (2001)
SC35 autoregulates its expression by promoting splicing events
that destabilize its mRNAs. EMBO J., 20, 1785–1796.
29. Stauffer,E., Westermann,A., Wagner,G. and Wachter,A. (2010)
Polypyrimidine tract-binding protein homologues from
Arabidopsis underlie regulatory circuits based on
alternative splicing and downstream control. Plant J., 64,
243–255.
30. Scho¨ning,J.C., Streitner,C., Meyer,I.M., Gao,Y. and Staiger,D.
(2008) Reciprocal regulation of glycine-rich RNA-binding proteins
via an interlocked feedback loop coupling alternative splicing to
nonsense-mediated decay in Arabidopsis. Nucleic Acids Res., 36,
6977–6987.
31. Streitner,C., Ko¨ster,T., Simpson,C.G., Shaw,P., Danisman,S.,
Brown,J.W.S. and Staiger,D. (2012) An hnRNP-like glycine-rich
RNA-binding protein affects alternative splicing by in vivo
interaction with target transcripts in Arabidopsis thaliana.
Nucleic Acids Res., 40, 11240–11255.
32. Thomas,J., Palusa,S.G., Prasad,K.V., Ali,G.S., Surabhi,G.K.,
Ben-Hur,A., Abdel-Ghany,S.E. and Reddy,A.S. (2012)
Identiﬁcation of an intronic splicing regulatory element involved
in auto-regulation of alternative splicing of SCL33 pre-mRNA.
Plant J., 72, 935–946.
33. Day,I.S., Golovkin,M., Palusa,S.G., Link,A., Ali,G.S., Thomas,J.,
Richardson,D.N. and Reddy,A.S. (2012) Interactions of SR45, an
SR-like protein, with spliceosomal proteins and an intronic
sequence: insights into regulated splicing. Plant J., 71, 936–947.
34. Ru¨hl,C., Stauffer,E., Kahles,A., Wagner,G., Drechsel,G.,
Ra¨tsch,G. and Wachter,A. (2012) Polypyrimidine tract binding
protein homologs from Arabidopsis are key regulators of
alternative splicing with implications in fundamental
developmental processes. Plant Cell, 24, 4360–4375.
35. Raczynska,K.D., Simpson,C.G., Ciesiolka,A., Szewc,L.,
Lewandowska,D., McNicol,J., Szweykowska-Kulinska,Z.,
Brown,J.W. and Jarmolowski,A. (2009) Involvement of
the nuclear cap-binding protein complex in alternative
splicing in Arabidopsis thaliana. Nucleic Acids Res., 38,
265–278.
36. Grigg,S.P., Canales,C., Hay,A. and Tsiantis,M. (2005) SERRATE
coordinates shoot meristem function and leaf axial patterning in
Arabidopsis. Nature, 437, 1022–1026.
37. Bezerra,I.C., Michaels,S.D., Schomburg,F.M. and Amasino,R.M.
(2004) Lesions in the mRNA cap-binding gene ABA
HYPERSENSITIVE 1 suppress FRIGIDA-mediated delayed
ﬂowering in Arabidopsis. Plant J., 40, 112–119.
Nucleic Acids Research, 2014, Vol. 42, No. 2 1243
 at U
niversity of D
undee on June 20, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
38. Hugouvieux,V., Kwak,J.M. and Schroeder,J.I. (2001) An mRNA
cap binding protein, ABH1, modulates early abscisic acid signal
transduction in Arabidopsis. Cell, 106, 477–487.
39. Papp,I., Mur,L.A., Dalmadi,A., Dulai,S. and Koncz,C. (2004) A
mutation in the cap binding protein 20 gene confers drought
tolerance to Arabidopsis. Plant Mol. Biol., 55, 679–686.
40. Lobbes,D., Rallapalli,G., Schmidt,D.D., Martin,C. and Clarke,J.
(2006) SERRATE: a new player on the plant microRNA scene.
EMBO Rep., 7, 1052–1058.
41. Yang,L., Liu,Z., Lu,F., Dong,A. and Huang,H. (2006)
SERRATE is a novel nuclear regulator in primary microRNA
processing in Arabidopsis. Plant J., 47, 841–850.
42. Dong,Z., Han,M.H. and Fedoroff,N. (2008) The RNA-binding
proteins HYL1 and SE promote accurate in vitro processing of
pri-miRNA by DCL1. Proc. Natl Acad. Sci. USA, 105,
9970–9975.
43. Laubinger,S., Sachsenberg,T., Zeller,G., Busch,W., Lohmann,J.U.,
Ra¨tsch,G. and Weigel,D. (2008) Dual roles of the nuclear cap-
binding complex and SERRATE in pre-mRNA splicing and
microRNA processing in Arabidopsis thaliana. Proc. Natl Acad.
Sci. USA, 105, 8795–8800.
44. Kim,S., Yang,J.Y., Xu,J., Jang,I.C., Prigge,M.J. and Chua,N.H.
(2008) Two cap-binding proteins CBP20 and CBP80 are involved
in processing primary MicroRNAs. Plant Cell. Physiol., 49,
1634–1644.
45. Gregory,B.D., O’Malley,R.C., Lister,R., Urich,M.A., Tonti-
Filippini,J., Chen,H., Millar,A.H. and Ecker,J.R. (2008) A link
between RNA metabolism and silencing affecting Arabidopsis
development. Dev. Cell, 14, 854–866.
46. Simpson,C.G., Fuller,J., Maronova,M., Kalyna,M., Davidson,D.,
McNicol,J., Barta,A. and Brown,J.W.S. (2008) Monitoring
changes in alternative precursor messenger RNA splicing in
multiple gene transcripts. Plant J., 53, 1035–1048.
47. Szarzynska,B., Sobkowiak,L., Pant,B.D., Balazadeh,S.,
Scheible,W.R., Mueller-Roeber,B., Jarmolowski,A. and
Szweykowska-Kulinska,Z. (2009) Gene structures and processing
of Arabidopsis thaliana HYL1-dependent pri-miRNAs. Nucleic
Acids Res., 37, 3083–3093.
48. Prigge,M.J. and Wagner,D.R. (2001) The Arabidopsis serrate
gene encodes a zinc-ﬁnger protein required for normal shoot
development. Plant Cell, 13, 1263–1279.
49. Schauer,S.E., Jacobsen,S.E., Meinke,D.W. and Ray,A. (2002)
DICER-LIKE1: blind men and elephants in Arabidopsis
development. Trends Plants Sci., 7, 487–491.
50. Axelos,M., Curie,C., Mazzolini,L., Bardet,C. and Lescure,B.
(1992) A protocol for transient gene expression in Arabidopsis
thaliana protoplasts isolated from cell suspension culture. Plant
Physiol. Biochem., 30, 123–128.
51. Tzﬁra,T., Tian,G.W., Lacroix,B., Vyas,S., Li,J., Leitner-Dagan,Y.,
Krichevsky,A., Taylor,T., Vainstain,A. and Citovsky,V. (2005)
pSAT vectors: a modular series of plasmids for autoﬂuorescent
protein tagging of multiple genes in plants. Plant Mol. Biol., 57,
503–516.
52. Citovsky,V., Lee,L.Y., Vyas,S., Glick,E., Chen,M.-H.,
Vainstein,A., Gafni,Y., Gelvin,S.B. and Tzﬁra,T. (2006)
Subcellular localization of interacting proteins by Bimolecular
Fluorescence Complementation in planta. J. Mol. Biol., 362,
1120–1131.
53. Goderis,I.J., De Bolle,M.F., Francois,I.E., Wouters,P.F.,
Broekaert,W.F. and Cammue,B.P. (2002) A set of modular plant
transformation vectors allowing ﬂexible insertion of up to six
expression units. Plant Mol. Biol., 50, 17–27.
54. He,P., Shan,L. and Sheen,J. (2007) The use of protoplasts to
study innate immune response. Methods Mol. Biol., 354, 1–9.
55. Kierzkowski,D., Kmieciak,M., Piontek,P., Wojtaszek,P.,
Szewykowska-Kulinska,Z. and Jarmolowski,A. (2009) The
Arabidopsis CBP20 targets the cap-binding complex to the
nucleus, and is stabilized by CBP80. Plant J., 59, 813–823.
56. Marion,J., Bach,L., Bellec,Y., Meyer,C., Gissot,L. and
Faure,J.-D. (2008) Systematic analysis of protein subcellular
localization and interaction using high-throughput transient
transformation of Arabidopsis seedlings. Plant J., 56, 169–179.
57. Wang,L., Song,X., Gu,L., Li,X., Cao,S., Chu,C., Cui,X., Chen,X.
and Cao,X. (2013) NOT2 proteins promote polymerase
II-dependent transcription and interact with multiple MicroRNA
biogenesis factors in Arabidopsis. Plant Cell., 25, 715–727.
58. Machida,S., Chen,H.Y. and Adam Yuan,Y. (2011) Molecular
insights into miRNA processing by Arabidopsis thaliana
SERRATE. Nucleic Acids Res., 39, 7828–7836.
59. Lenasi,T., Peterlin,B.M. and Barboric,M. (2011) Cap-binding
protein complex links pre-mRNA capping to transcription
elongation and alternative splicing through positive transcription
elongation factor b (P-TEFb). J Biol. Chem., 286, 22758–22768.
60. Gruber,J.J., Zatechka,D.S., Sabin,L.R., Yong,J., Lum,J.J.,
Kong,M., Zong,W.X., Zhang,Z., Lau,C.K., Rawlings,J. et al.
(2009) Ars2 links the nuclear cap-binding complex to RNA
interference and cell proliferation. Cell, 138, 328–339.
61. Fang,Y. and Spector,D.L. (2007) Identiﬁcation of nuclear dicing
bodies containing proteins for microRNA biogenesis in living
Arabidopsis plants. Curr. Biol., 17, 818–823.
62. Hugouvieux,V., Kwak,J.M. and Schroeder,J.I. (2001) An mRNA
cap binding protein, ABH1, modulates early abscisic acid signal
transduction in Arabidopsis. Cell, 106, 477–487.
63. Hugouvieux,V., Murata,Y., Young,J.J., Kwak,J.M., Mackesy,D.Z.
and Schroeder,J.I. (2002) Localization, ion channel regulation,
and genetic interactions during abscisic acid signaling of the
nuclear mRNA cap-binding protein, ABH1. Plant Physiol., 130,
1276–1287.
64. Papp,I., Mur,L.A., Dalmadi,A., Dulai,S. and Koncz,C. (2004) A
mutation in the cap binding protein 20 gene confers drought
tolerance to Arabidopsis. Plant Mol. Biol., 55, 679–686.
65. Fujioka,Y., Utsumi,M., Ohba,Y. and Watanabe,Y. (2007)
Location of a possible miRNA processing site in SmD3/SmB
nuclear bodies in Arabidopsis. Plant Cell Physiol., 48, 1243–1253.
66. Christie,M., Croft,L.J. and Carroll,B.J. (2011) Intron splicing
suppresses RNA silencing in Arabidopsis. Plant J., 68, 159–167.
67. Christie,M. and Carroll,B.J. (2011) SERRATE is required for
intron suppression of RNA silencing in Arabidopsis. Plant Signal
Behav., 6, 2035–2037.
68. Sabin,L.R., Zhou,R., Gruber,J.J., Lukinova,N., Bambina,S.,
Berman,A., Lau,C.K., Thompson,C.B. and Cherry,S. (2009) Ars2
regulates both miRNA- and siRNA- dependent silencing and
suppresses RNA virus infection in Drosophila. Cell, 138, 340–351.
69. Sobkowiak,L., Karlowski,W., Jarmolowski,A. and Szweykowska-
Kulinska,Z. (2012) Non-canonical processing of Arabidopsis pri-
miR319a/b/c generates additional microRNAs to target one
RAP2.12 mRNA isoform. Front. Plant Sci., 3, 46.
70. Yan,K., Liu,P., Wu,C.A., Yang,G.D., Xu,R., Guo,Q.H.,
Huang,J.G. and Zheng,C.C. (2012) Stress-induced alternative
splicing provides a mechanism for the regulation of MicroRNA
processing in Arabidopsis thaliana. Mol. Cell, 48, 521–531.
71. Lu,C. and Fedoroff,N. (2000) A mutation in the Arabidopsis
HYL1 gene encoding a dsRNA binding protein affects responses
to abscisic acid, auxin, and cytokinin. Plant Cell, 12, 2351–2366.
72. Tagami,Y., Motose,H. and Watanabe,Y. (2009) A dominant
mutation in DCL1 suppresses the hyl1 mutant phenotype by
promoting the processing of miRNA. RNA, 15, 450–458.
73. Yang,S.W., Chen,H.Y., Yang,J., Machida,S., Chua,N.H. and
Yuan,Y.A. (2010) Structure of Arabidopsis HYPONASTIC
LEAVES1 and its molecular implications for miRNA processing.
Structure, 18, 594–605.
74. Ma,E., MacRae,I.J., Kirsch,J.F. and Doudna,J.A. (2008)
Autoinhibition of human dicer by its internal helicase domain.
J. Mol. Biol., 380, 237–243.
75. Luco,R.F., Pan,Q., Tominaga,K., Blencowe,B.J., Pereira-
Smith,O.M. and Misteli,T. (2010) Regulation of alternative
splicing by histone modiﬁcations. Science, 327, 996–1000.
76. Pouch-Pe´lissier,M.N., Pe´lissier,T., Elmayan,T., Vaucheret,H.,
Boko,D., Jantsch,M.F. and Deragon,J.M. (2008) SINE RNA
induces severe developmental defects in Arabidopsis thaliana and
interacts with HYL1 (DRB1), a key member of the DCL1
complex. PLoS Genet., 4, 1000096.
77. Vazquez,F. (2006) Arabidopsis endogenous small RNAs:
highways and byways. Trends Plant Sci., 11, 460–468.
1244 Nucleic Acids Research, 2014, Vol. 42, No. 2
 at U
niversity of D
undee on June 20, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
